BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

786 related articles for article (PubMed ID: 11861412)

  • 1. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly.
    Galis ZS; Khatri JJ
    Circ Res; 2002 Feb; 90(3):251-62. PubMed ID: 11861412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture.
    Newby AC
    Physiol Rev; 2005 Jan; 85(1):1-31. PubMed ID: 15618476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular remodeling and protease inhibition--bench to bedside.
    Sluijter JP; de Kleijn DP; Pasterkamp G
    Cardiovasc Res; 2006 Feb; 69(3):595-603. PubMed ID: 16387286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What has been learned about the cardiovascular effects of matrix metalloproteinases from mouse models?
    Janssens S; Lijnen HR
    Cardiovasc Res; 2006 Feb; 69(3):585-94. PubMed ID: 16426591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmin and matrix metalloproteinases in vascular remodeling.
    Lijnen HR
    Thromb Haemost; 2001 Jul; 86(1):324-33. PubMed ID: 11487021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanism for activation and regulation of matrix metalloproteinases during bacterial infections and respiratory inflammation.
    Okamoto T; Akuta T; Tamura F; van Der Vliet A; Akaike T
    Biol Chem; 2004 Nov; 385(11):997-1006. PubMed ID: 15576319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability.
    Johnson JL
    Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):265-82. PubMed ID: 17338671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
    Stalmans I
    Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of matrix metalloproteinases in the inflammatory process of respiratory diseases.
    Lagente V; Boichot E
    J Mol Cell Cardiol; 2010 Mar; 48(3):440-4. PubMed ID: 19818795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage-mediated proteolytic remodeling of the extracellular matrix in atherosclerosis results in neoepitopes: a potential new class of biochemical markers.
    Skjøt-Arkil H; Barascuk N; Register T; Karsdal MA
    Assay Drug Dev Technol; 2010 Oct; 8(5):542-52. PubMed ID: 20662734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases.
    Gueders MM; Foidart JM; Noel A; Cataldo DD
    Eur J Pharmacol; 2006 Mar; 533(1-3):133-44. PubMed ID: 16487964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinases in vascular physiology and disease.
    Siefert SA; Sarkar R
    Vascular; 2012 Aug; 20(4):210-6. PubMed ID: 22896663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular imaging of matrix metalloproteinases in atherosclerotic plaques.
    Lenglet S; Thomas A; Chaurand P; Galan K; Mach F; Montecucco F
    Thromb Haemost; 2012 Mar; 107(3):409-16. PubMed ID: 22274652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of matrix metalloproteinases in the oral environment.
    Hannas AR; Pereira JC; Granjeiro JM; Tjäderhane L
    Acta Odontol Scand; 2007 Feb; 65(1):1-13. PubMed ID: 17354089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Special characteristics of atherosclerosis in chronic renal failure.
    Amann K; Tyralla K; Gross ML; Eifert T; Adamczak M; Ritz E
    Clin Nephrol; 2003 Jul; 60 Suppl 1():S13-21. PubMed ID: 12940530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction.
    Schmidt R; Bültmann A; Ungerer M; Joghetaei N; Bülbül O; Thieme S; Chavakis T; Toole BP; Gawaz M; Schömig A; May AE
    Circulation; 2006 Feb; 113(6):834-41. PubMed ID: 16461815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Matrix metalloproteinases and atherosclerosis. Therapeutic aspects].
    Beaudeux JL; Giral P; Bruckert E; Foglietti MJ; Chapman MJ
    Ann Biol Clin (Paris); 2003; 61(2):147-58. PubMed ID: 12702469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular degradative pathways in myocardial remodeling and progression to heart failure.
    Spinale FG; Gunasinghe H; Sprunger PD; Baskin JM; Bradham WC
    J Card Fail; 2002 Dec; 8(6 Suppl):S332-8. PubMed ID: 12555141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of matrix metalloproteinases and tenascin-C in elastin calcification.
    Bailey M; Pillarisetti S; Jones P; Xiao H; Simionescu D; Vyavahare N
    Cardiovasc Pathol; 2004; 13(3):146-55. PubMed ID: 15081471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of concepts: cardiac extracellular matrix remodeling after myocardial infarction.
    Cleutjens JP; Creemers EE
    J Card Fail; 2002 Dec; 8(6 Suppl):S344-8. PubMed ID: 12555143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.